GB
Gil Blum Needham Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
144
Avg Return
Past Year
Past Year
2.1%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
75%
Neutral
5%
Negative
20%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $10 |
112%
upside
| 2 | +18% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Buy
Reiterated
| $18 |
200%
upside
| 1 | +7.9% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Buy
Reiterated
| $81 |
17%
upside
| 1 | +5.6% |
0
%
| 10 Oct ‘25 9 days ago |
|
|
|
Buy
Reiterated
| $70 |
35%
upside
| 3 | +31% |
0
%
| 3 Oct ‘25 16 days ago |
|
|
|
Buy
Upgraded
| $14 |
74%
upside
| 1 | +0.88% |
0
%
| 18 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $8 |
37%
upside
| 1 | +0.78% |
0
%
| 11 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $6 |
4%
upside
| 2 | +63% |
0
%
| 8 Sep ‘25 1 month ago |
|
|
|
Buy
Reiterated
| $15 |
143%
upside
| 1 | -12% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $10 |
335%
upside
| 1 | -0.38% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $8 |
77%
upside
| 1 | +11% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Underperform
Reiterated
| – | – | 4 | -14% |
0
%
| 29 Jul ‘25 2 months ago |
|
|
|
Hold
Maintained
| – | – | 1 | -18% |
0
%
| 24 Jul ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $10 |
517%
upside
| 1 | -3.5% |
0
%
| 21 Jul ‘25 3 months ago |
|